Cargando…
Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
Migraine is the most common neurological disorder, and contributes to disability and large healthcare costs in the United States and the world. The treatment of migraine until recently has focused on medications, both abortive and prophylactic, but treatment of chronic migraine has been revolutioniz...
Autores principales: | Schaefer, Sara M., Gottschalk, Christopher H., Jabbari, Bahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516932/ https://www.ncbi.nlm.nih.gov/pubmed/26184313 http://dx.doi.org/10.3390/toxins7072615 |
Ejemplares similares
-
Botulinum Neurotoxins and Cancer—A Review of the Literature
por: Mittal, Shivam O., et al.
Publicado: (2020) -
Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
por: Valente, Mariarosaria, et al.
Publicado: (2021) -
Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
por: Sandrini, Giorgio, et al.
Publicado: (2017) -
History of Botulinum Toxin Treatment in Movement Disorders
por: Jabbari, Bahman
Publicado: (2016) -
Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)